
HealthTurku
Overview
About us
TSCP (Turku Science Park Ltd) acts as a coordinator of HealthTurku cluster comprising of more than 90 enterprises and Health Campus Turku network with two universities, a university hospital and two universities of applied sciences. TSCP offers business development services that cover the entire lifecycle of entrepreneurial activities, ranging from testing a business idea and establishing a company to internationalisation and expanding of international business operations. TSCP also runs activities of the first Life Science Accelerator in Finland.
TSCP acts as a strategic partner of universities and enterprises to promote innovation and business. TSCP serves all lines of business, but the focal fields are biotechnology (HealthTurku/ BioTurku® – life sciences), information and communication technology (ICT), chemical industry and cleantech, future technologies (manufacturing industry, maritime industry), as well as experience industry (games, movies). TSCP is a member of the Enterprise Europe Network and furthermore, member of ScanBalt Bioregion and Council of European Bioregions.
TSCP is an independent and impartial expert company which has promoted the business based on leading know-how for more than 25 years.
Cluster composition
-
100Cluster Members
-
80SME's
-
3Large Companies
-
4Research Organisations, Universities, Technology Centers
-
100Other Ecosystem Actors
Management team
Sectorial and industrial focus
Sectoral Industries
Technology fields
S3 EU priority areas
Cross-sectoral industries
Services
Support services provided
Support programmes
EU Programmes
Name & description
Project name
Several EU funded projects :
- Life Science Accelerator - Life Science Accelerator is a new national accelerator concept run by Turku Science Park Ltd. It serves life science research projects and start-ups from idea to commercialisation. The project is partly funded by ERDF. http://www.lifesci.ac/
- EEN - Turku Science Park Ltd has been a member of EEN network since 2009 (COSME funding)
- BIC - Biomarker Commercialisation, a project that aims to set up a tool and platform to accompany the biomarker development pathway at every stage, and bring the industry, including pharmaceutical and diagnostic enterprises, SMEs and investors, to participate as early as possible in the development process (Interreg BSR funding) https://projects.interreg-baltic.eu/projects/bic-106.html
- CB Health Access - Aim of the project is to add SMEs' market know-how and business outside EU; South Korea, India, Uganda, Maryland/USA (Central Baltic Interreg funding)
Cooperation activities
International cooperation
Targeted countries
Transnational cooperation
Targeted countries
Transnational support activites
International support activites
Support to collaborative activities/etc.Upcoming events
Monday | Tuesday | Wednesday | Thursday | Friday | Saturday | Sunday |
---|---|---|---|---|---|---|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|